Doing more than the expected so health science can do more for the world
At Cohance Lifesciences, quality is not a department. It is a deeply embedded mindset—an organizational consciousness that shapes every decision, every action, and every solution we deliver. As a global CDMO committed to advancing health science, our Quality and Compliance practices are guided by scientific integrity, regulatory vigilance, and a shared responsibility to improve human lives.
Setting the Bar, and then Raising It
Setting the Bar, and then Raising It
Our unwavering commitment to quality begins with a simple yet powerful belief: people deserve the best. That is why we do not just adhere to global standards—we consistently exceed them. From research and development to manufacturing and distribution, every product we create aligns with the most rigorous global regulatory requirements, ensuring Safety, Identity, Strength, Purity and Quality (SISPQ). This standard of excellence underpins our promise to patients across the world.
Built on Values, Powered by Culture
Quality at Cohance is more than just a process—it is a culture. Our core values—Customer First, Accountability, Sustainability, Trust, and Empowerment—fuel a collective commitment to continuous improvement and patient well-being. Every individual is empowered to take ownership of quality outcomes, creating a proactive, detail-oriented environment where excellence is a shared pursuit.
Driven by Experts Who Shape Global Outcomes
Driven by Experts Who Shape Global Outcomes
Our Quality and Regulatory Affairs team is one of our strategic assets. Our teams in QA, QC, CQA, DQA, and RA embed quality into the very DNA of every product, process, and delivery. Their expertise not only secures regulatory compliance but also strengthens our ability to meet evolving customer expectations and global market access needs.
Regulatory Excellence: A Pillar of Trust
Navigating the complex global regulatory landscape is a responsibility we take seriously. We design our operations for compliance at every step—from development through distribution—so we consistently meet and often exceed the expectations of health authorities across geographies. This approach reinforces the trust placed in us by our partners, patients, and regulators worldwide.
Globally Approved, Locally Accountable
Globally Approved, Locally Accountable
Our facilities across API, FDF units carry prestigious approvals from health authorities such as the US FDA, EDQM, PMDA, ANVISA, WHO-GMP, KFDA, COFEPRIS, HEALTH CANADA, MHRA, and DCA, among others. These approvals are more than checkmarks—they are a reflection of our discipline, consistency, and commitment to making high-quality pharmaceuticals accessible across borders.
Integrated Quality Management without Borders
Our Integrated Global Quality System is a unified framework that ensures every Cohance product—regardless of where it is developed or manufactured—meets the highest international benchmarks. By harmonizing standards, processes, and compliance practices across our network, we guarantee consistency in quality and safety from lab to market.
Strengthened by Digitalization
Strengthened by Digitalization
We are embracing digital transformation to make our Quality Management System even more agile and intelligent. We use digital tools and automation to enhance data integrity, improve traceability, and ensure faster, more reliable compliance with both global and local regulations. This ongoing digital evolution reflects our future-ready commitment to patient safety and operational excellence. For a healthier world. That is our commitment, without compromise.
Our Global Accreditations
At Cohance Lifesciences, every facility stands as a testament to our uncompromised commitment to quality. Below is a snapshot of the regulatory approvals and certifications that reinforce our global credibility:
Generic API Facilities
- API Unit-I , Jaggayapet, Andhra Pradesh, India.
- • US FDA, PMDA, Russia MOH, KFDA, COFEPRIS, CDSCO, DCA, ANVISA, EDQM.
- API Unit-II, Atchutapuram, Andhra Pradesh, India.
- • EDQM, DCA.
- API Unit-III, Ankleshwar, Gujarat, India.
- • US FDA, EDQM, PMDA, KFDA, ANVISA, COFEPRIS, DCA.
Small Molecule CDMO Facilities
- CDMO Unit-III, Pashamylaram, Telangana, India.
- • US FDA, EDQM, BGV, ANVISA, PMDA, KFDA, WHO GMP.
- API Unit-IV, Nacharam, Telangana, India.
- • US FDA, EU, CDSCO, DCA.
- API Unit-V, Parwada, Andhra Pradesh, India.
- • ISO, DCA.
FDF Facilities
- FDF Unit-I, Nacharam, Telangana, India.
- • US FDA, Health Canada, MHRA, ANVISA, COFEPRIS, Russia MOH, TGA, Philippines FDA, Tanzania FDA, Uganda NDA, SFDA, CDSCO, DCA, EDQM.
- FDF Unit-II, Jadcherla, Telangana, India.
- • CDSCO, DCA.
- FDF Unit-III, Pashamylaram, Telangana, India
- • CDSCO, DCA, US FDA, EDQM.
- FDF Unit-IV, Shamshabad, Telangana, India.
- • US FDA, DCA.